![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://pub.mdpi-res.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001-550.jpg?1571315946)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://pub.mdpi-res.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001.png?1571315946)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/adf2d3f5-f120-4033-88a6-3fc175a7a0aa/gr1.jpg)
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men | PLOS ONE
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/4-Figure2-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
![PDF) Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer | Mathew Fakhoury - Academia.edu PDF) Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer | Mathew Fakhoury - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/41731654/mini_magick20190218-25752-1mp8st3.png?1550543122)
PDF) Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer | Mathew Fakhoury - Academia.edu
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig1_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort | PLOS ONE
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig2_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/bec00aa2-b5ad-45b7-8119-8e9f432e8d80/gr1_lrg.jpg)
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus
![Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429514002490-gr1.jpg)
Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![Augmenting prostate magnetic resonance imaging reporting to incorporate diagnostic recommendations based upon clinical risk calculators Augmenting prostate magnetic resonance imaging reporting to incorporate diagnostic recommendations based upon clinical risk calculators](https://f6publishing.blob.core.windows.net/f97601d0-3db0-48c3-a4db-2d85f29d7cbd/WJR-14-249-g002.png)
Augmenting prostate magnetic resonance imaging reporting to incorporate diagnostic recommendations based upon clinical risk calculators
![Predicción de riesgo de adenocarcinoma prostático con el uso del Prostate Cancer Prevention Trial Risk Calculator en una cohorte colombiana | Urología Colombiana Predicción de riesgo de adenocarcinoma prostático con el uso del Prostate Cancer Prevention Trial Risk Calculator en una cohorte colombiana | Urología Colombiana](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//0120789X/0000002400000001/v1_201505280916/S0120789X15000064/v1_201505280916/es/main.assets/gr6.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNeHY/QGUNNnKwMNr/rJBysWvc6dVEsF6Ei531PKxD9sCUE1+pTRTJVzs1Hmdjakr2IxP+ebj2HKfSNWLS34j4R8wYWVm+XF4OBe7JaYNHwOg8309TK+MqjOwbggMwN0lYphdQC9FT+N44WLPfcgtPN74N8bRDhXj13eexT/d3HQ+3V+X26XEFwucB2gBLA9V/NDFWQ0vgEZ7VsBu2/LTjRXu34FT/KavmSrgr6GEszlJBPVw+xnUtacNcTDVyCSjsU=)
Predicción de riesgo de adenocarcinoma prostático con el uso del Prostate Cancer Prevention Trial Risk Calculator en una cohorte colombiana | Urología Colombiana
The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating
![Calibration curve comparisons between the Prostate Cancer Prevention... | Download Scientific Diagram Calibration curve comparisons between the Prostate Cancer Prevention... | Download Scientific Diagram](https://www.researchgate.net/publication/51235801/figure/fig1/AS:340628153094145@1458223488221/Calibration-curve-comparisons-between-the-Prostate-Cancer-Prevention-Trial-PCPT-based.png)
Calibration curve comparisons between the Prostate Cancer Prevention... | Download Scientific Diagram
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/2-Table1-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
Performance of Prostate Cancer Prevention Trial Risk Calculator in a Contemporary Cohort Screened for Prostate Cancer and Diagno
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig1_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![PDF) Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: A Performance Comparison in a Contemporary Screened Cohort | Luis Osorio - Academia.edu PDF) Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer Risk Calculators: A Performance Comparison in a Contemporary Screened Cohort | Luis Osorio - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40062580/mini_magick20190221-13720-1hz0uib.png?1550821189)